Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and image analysis
Real-time, label free cell analysis
Nano and micro particle analysis
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Webinar recording: Autofluorescence management - the power of Spectral Flow Cytometry
Jul 15, 2021
One of the key advantages of spectral flow cytometry is its ability to extract sample autofluorescence, making it much...
ACCELA webinar recording : IntraVital Microscopy (IVM): In Vivo Live Cell Imaging Platform
Jul 13, 2021
Intravital microscopy can visualize...
Webinar recording: Super-Resolution imaging of Chromatin organization in health and disease
Jul 6, 2021
Understanding how cells organize the array of components within their membranous confines can not only provide insight...
Jun 10, 2021
NanoView Biosciences has developed...
Understanding bacterial biofilms more than ever before with BioFlux kinetic shear flow system
Jun 9, 2021
Bacteria and fungi organized into...
Jun 7, 2021
We look forward to welcoming many of our users to 2021 PMOD User Meeting. The theme of our PMOD User Meeting will be...
IncuCyte webinar recording: How to measure Immune Cell Killing of Tumor Cells effectively
Jun 4, 2021
Immuno-oncology (IO) has transformed cancer treatment. The number of treatments in the IO pipeline continues to...
Bruker webinar: Experiences in The Use of Micro-CT in Insect Research
Jun 3, 2021
High resolution micro-CT is being used routinely in science. Mostly it is being used as a substitute to microscopy to...
Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST
Oct 13, 2016
Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).
Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
